Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for ID4_TCF4_SNAI2
Z-value: 3.47
Motif logo
Transcription factors associated with ID4_TCF4_SNAI2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ID4
|
ENSG00000172201.6 | inhibitor of DNA binding 4, HLH protein |
|
TCF4
|
ENSG00000196628.9 | transcription factor 4 |
|
SNAI2
|
ENSG00000019549.4 | snail family transcriptional repressor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| SNAI2 | hg19_v2_chr8_-_49834299_49834446, hg19_v2_chr8_-_49833978_49833996 | -0.54 | 9.4e-18 | Click! |
| TCF4 | hg19_v2_chr18_-_53303123_53303190 | 0.33 | 5.2e-07 | Click! |
| ID4 | hg19_v2_chr6_+_19837592_19837621 | 0.25 | 1.5e-04 | Click! |
Activity profile of ID4_TCF4_SNAI2 motif
Sorted Z-values of ID4_TCF4_SNAI2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of ID4_TCF4_SNAI2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 39.7 | 158.9 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 29.1 | 87.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 27.6 | 165.3 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 21.8 | 109.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 15.3 | 61.3 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 15.1 | 90.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 15.0 | 44.9 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 14.6 | 43.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 14.1 | 56.4 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 13.6 | 54.5 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 13.4 | 80.4 | GO:1902998 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 12.7 | 101.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 12.2 | 36.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 12.1 | 12.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 11.6 | 34.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 11.5 | 57.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 11.4 | 11.4 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
| 11.0 | 99.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 10.9 | 32.7 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 10.8 | 172.7 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 10.5 | 42.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
| 10.4 | 31.3 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 10.4 | 41.5 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 10.2 | 40.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 9.8 | 78.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 9.4 | 37.6 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 9.2 | 9.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 9.1 | 54.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 8.9 | 44.6 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 8.8 | 8.8 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 8.8 | 26.4 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 8.6 | 25.8 | GO:2001302 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 8.6 | 34.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 8.5 | 34.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 8.5 | 42.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 8.5 | 25.5 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 8.5 | 42.4 | GO:0002159 | desmosome assembly(GO:0002159) |
| 8.4 | 25.3 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 8.3 | 25.0 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 8.2 | 40.8 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 8.0 | 39.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 8.0 | 31.8 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 7.9 | 7.9 | GO:0042048 | olfactory behavior(GO:0042048) |
| 7.9 | 63.0 | GO:0015705 | iodide transport(GO:0015705) |
| 7.7 | 23.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 7.6 | 60.4 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 7.5 | 30.1 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 7.5 | 74.9 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 7.4 | 29.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 7.4 | 22.1 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 7.3 | 14.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 7.3 | 21.9 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
| 7.3 | 36.3 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 7.2 | 57.6 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 7.2 | 35.8 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 7.1 | 21.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 6.9 | 34.4 | GO:0048478 | replication fork protection(GO:0048478) |
| 6.9 | 27.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 6.8 | 6.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
| 6.8 | 40.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 6.8 | 33.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 6.8 | 20.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 6.7 | 20.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 6.5 | 6.5 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 6.4 | 19.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 6.4 | 12.8 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 6.4 | 19.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 6.3 | 19.0 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
| 6.3 | 31.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 6.3 | 31.5 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 6.3 | 6.3 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 6.2 | 18.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 6.2 | 37.1 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 6.1 | 12.1 | GO:0035878 | nail development(GO:0035878) |
| 6.0 | 18.1 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 6.0 | 18.0 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 6.0 | 6.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation(GO:0030497) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 6.0 | 35.7 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 5.9 | 17.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 5.9 | 35.5 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 5.9 | 11.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 5.9 | 17.6 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 5.8 | 29.0 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 5.8 | 17.3 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 5.7 | 11.4 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 5.7 | 22.6 | GO:0035106 | operant conditioning(GO:0035106) |
| 5.6 | 33.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 5.6 | 33.5 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 5.5 | 22.0 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 5.5 | 49.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 5.4 | 10.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 5.4 | 5.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 5.4 | 32.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 5.4 | 26.9 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
| 5.4 | 21.4 | GO:0006562 | proline catabolic process(GO:0006562) |
| 5.2 | 26.2 | GO:0015744 | succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 5.2 | 10.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 5.2 | 30.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 5.1 | 15.3 | GO:0032898 | neurotrophin production(GO:0032898) |
| 5.0 | 20.2 | GO:2000538 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 5.0 | 15.1 | GO:1905166 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 5.0 | 49.7 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
| 4.9 | 14.8 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 4.9 | 14.7 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 4.9 | 14.6 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 4.8 | 29.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 4.8 | 29.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 4.8 | 19.3 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 4.8 | 9.6 | GO:0045453 | bone resorption(GO:0045453) |
| 4.8 | 33.7 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 4.8 | 14.4 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 4.8 | 47.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 4.8 | 19.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 4.7 | 14.2 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
| 4.7 | 18.9 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 4.7 | 33.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 4.7 | 14.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 4.7 | 33.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 4.7 | 14.2 | GO:0033483 | gas homeostasis(GO:0033483) |
| 4.7 | 32.6 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 4.6 | 134.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 4.6 | 4.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 4.6 | 18.2 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 4.5 | 18.1 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 4.5 | 13.5 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 4.5 | 17.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 4.5 | 4.5 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
| 4.4 | 17.8 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 4.4 | 8.8 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
| 4.4 | 13.3 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 4.4 | 13.1 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 4.4 | 17.5 | GO:1904640 | response to methionine(GO:1904640) |
| 4.4 | 21.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 4.4 | 21.8 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 4.3 | 69.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 4.3 | 4.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 4.3 | 26.0 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 4.3 | 8.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 4.3 | 25.8 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 4.3 | 12.9 | GO:0021888 | hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 4.3 | 21.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 4.3 | 12.8 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 4.2 | 4.2 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 4.2 | 12.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 4.2 | 17.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 4.2 | 25.4 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 4.2 | 16.8 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 4.2 | 54.5 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 4.2 | 20.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 4.1 | 12.4 | GO:0033214 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 4.1 | 28.7 | GO:0048241 | epinephrine transport(GO:0048241) |
| 4.1 | 20.5 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 4.1 | 32.5 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 4.1 | 24.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 4.1 | 4.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
| 4.0 | 12.1 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 4.0 | 12.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 4.0 | 28.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 4.0 | 12.1 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 4.0 | 12.0 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 4.0 | 31.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 3.9 | 54.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 3.9 | 11.7 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 3.9 | 3.9 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 3.9 | 31.0 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 3.9 | 7.7 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
| 3.9 | 3.9 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 3.8 | 11.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 3.8 | 15.2 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 3.8 | 15.1 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 3.7 | 3.7 | GO:1905075 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 3.7 | 11.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 3.7 | 11.1 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 3.7 | 3.7 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 3.7 | 11.0 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 3.7 | 54.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 3.7 | 14.6 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 3.7 | 11.0 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 3.6 | 14.6 | GO:0003335 | corneocyte development(GO:0003335) |
| 3.6 | 10.9 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
| 3.6 | 21.7 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 3.6 | 10.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 3.6 | 39.5 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 3.6 | 7.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 3.6 | 14.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
| 3.5 | 31.8 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
| 3.5 | 10.6 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 3.5 | 35.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 3.5 | 7.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 3.5 | 7.0 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
| 3.5 | 7.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 3.5 | 41.8 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 3.5 | 13.9 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 3.5 | 3.5 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 3.5 | 3.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 3.5 | 6.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 3.5 | 17.3 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 3.4 | 3.4 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 3.4 | 10.3 | GO:0001510 | RNA methylation(GO:0001510) |
| 3.4 | 13.8 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 3.4 | 51.7 | GO:0006751 | glutathione catabolic process(GO:0006751) |
| 3.4 | 13.7 | GO:0036269 | swimming behavior(GO:0036269) |
| 3.4 | 6.9 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
| 3.4 | 6.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 3.4 | 51.0 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
| 3.4 | 13.6 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 3.4 | 13.6 | GO:0015942 | formate metabolic process(GO:0015942) |
| 3.4 | 10.1 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
| 3.4 | 16.9 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 3.4 | 10.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 3.4 | 3.4 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 3.4 | 6.7 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 3.4 | 57.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 3.3 | 13.3 | GO:0019086 | late viral transcription(GO:0019086) |
| 3.3 | 36.7 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 3.3 | 16.6 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 3.3 | 3.3 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 3.3 | 16.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 3.3 | 9.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 3.3 | 29.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 3.3 | 144.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 3.3 | 3.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 3.3 | 62.3 | GO:0097484 | dendrite extension(GO:0097484) |
| 3.3 | 6.5 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 3.3 | 42.5 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 3.3 | 35.8 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 3.2 | 16.2 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 3.2 | 9.7 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 3.2 | 77.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 3.2 | 12.9 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 3.2 | 19.3 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 3.2 | 16.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 3.2 | 41.7 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 3.2 | 6.4 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 3.2 | 22.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 3.2 | 19.2 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 3.2 | 3.2 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 3.2 | 31.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 3.2 | 12.7 | GO:0017121 | phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
| 3.2 | 25.5 | GO:0070236 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 3.2 | 3.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 3.2 | 12.7 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 3.2 | 9.5 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 3.1 | 15.7 | GO:0030070 | insulin processing(GO:0030070) |
| 3.1 | 12.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 3.1 | 9.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 3.1 | 21.7 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 3.1 | 12.4 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 3.1 | 12.4 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 3.1 | 9.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 3.1 | 15.4 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 3.1 | 12.2 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 3.0 | 24.4 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 3.0 | 3.0 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
| 3.0 | 24.3 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 3.0 | 57.6 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 3.0 | 3.0 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
| 3.0 | 9.1 | GO:0048850 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
| 3.0 | 5.9 | GO:1901859 | base-excision repair, DNA ligation(GO:0006288) negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 3.0 | 5.9 | GO:0001575 | globoside metabolic process(GO:0001575) |
| 3.0 | 8.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 3.0 | 20.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 3.0 | 41.4 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 3.0 | 23.6 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 2.9 | 38.3 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 2.9 | 8.8 | GO:0009107 | lipoate biosynthetic process(GO:0009107) |
| 2.9 | 32.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 2.9 | 5.9 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
| 2.9 | 2.9 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 2.9 | 35.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 2.9 | 8.8 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 2.9 | 2.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 2.9 | 11.7 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 2.9 | 72.8 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 2.9 | 17.5 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 2.9 | 5.8 | GO:0009409 | response to cold(GO:0009409) |
| 2.9 | 5.8 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 2.9 | 5.7 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
| 2.9 | 2.9 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 2.8 | 5.7 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 2.8 | 19.9 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 2.8 | 5.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 2.8 | 8.4 | GO:1901993 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 2.8 | 2.8 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
| 2.8 | 2.8 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
| 2.8 | 11.2 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 2.8 | 50.4 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 2.8 | 19.6 | GO:0071156 | regulation of cell cycle arrest(GO:0071156) positive regulation of cell cycle arrest(GO:0071158) |
| 2.8 | 2.8 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 2.8 | 11.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 2.8 | 16.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 2.8 | 11.0 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 2.8 | 41.3 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 2.7 | 13.7 | GO:1990834 | response to odorant(GO:1990834) |
| 2.7 | 13.7 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 2.7 | 54.7 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 2.7 | 54.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 2.7 | 8.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 2.7 | 19.0 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 2.7 | 5.4 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
| 2.7 | 5.4 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
| 2.7 | 10.8 | GO:2000341 | regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
| 2.7 | 10.8 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 2.7 | 8.0 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 2.7 | 5.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 2.7 | 8.0 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 2.7 | 2.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 2.7 | 5.3 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 2.7 | 10.6 | GO:0061743 | motor learning(GO:0061743) |
| 2.7 | 5.3 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 2.6 | 5.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 2.6 | 23.8 | GO:0097186 | amelogenesis(GO:0097186) |
| 2.6 | 5.3 | GO:0033762 | response to glucagon(GO:0033762) |
| 2.6 | 15.8 | GO:1903276 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 2.6 | 10.5 | GO:0002438 | acute inflammatory response to antigenic stimulus(GO:0002438) |
| 2.6 | 7.9 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 2.6 | 7.9 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 2.6 | 2.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 2.6 | 7.8 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 2.6 | 10.4 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 2.6 | 18.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 2.6 | 13.0 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 2.6 | 7.8 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 2.6 | 15.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
| 2.6 | 5.2 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 2.6 | 28.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 2.6 | 20.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 2.6 | 28.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 2.6 | 7.7 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 2.5 | 22.9 | GO:0000050 | urea cycle(GO:0000050) |
| 2.5 | 17.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 2.5 | 7.6 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 2.5 | 5.1 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
| 2.5 | 5.1 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 2.5 | 17.7 | GO:0042426 | choline catabolic process(GO:0042426) |
| 2.5 | 7.6 | GO:0071529 | cementum mineralization(GO:0071529) |
| 2.5 | 15.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 2.5 | 5.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 2.5 | 20.2 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 2.5 | 22.7 | GO:0006477 | protein sulfation(GO:0006477) |
| 2.5 | 7.6 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 2.5 | 7.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 2.5 | 10.0 | GO:0061047 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
| 2.5 | 17.5 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 2.5 | 37.5 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 2.5 | 7.5 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 2.5 | 32.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 2.5 | 17.4 | GO:1900619 | acetylcholine metabolic process(GO:0008291) acetate ester metabolic process(GO:1900619) |
| 2.5 | 7.5 | GO:0100009 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 2.5 | 5.0 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 2.5 | 9.9 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 2.5 | 12.3 | GO:0061744 | motor behavior(GO:0061744) |
| 2.5 | 12.3 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 2.5 | 7.4 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 2.5 | 14.7 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
| 2.5 | 7.4 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 2.5 | 46.6 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 2.4 | 4.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 2.4 | 7.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
| 2.4 | 21.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 2.4 | 4.9 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 2.4 | 31.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 2.4 | 2.4 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 2.4 | 9.7 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 2.4 | 24.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 2.4 | 14.5 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 2.4 | 7.2 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 2.4 | 16.9 | GO:0060174 | limb bud formation(GO:0060174) |
| 2.4 | 16.9 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 2.4 | 16.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
| 2.4 | 7.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 2.4 | 2.4 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 2.4 | 4.8 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 2.4 | 4.7 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
| 2.4 | 30.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 2.4 | 9.5 | GO:1902075 | cellular response to salt(GO:1902075) |
| 2.4 | 7.1 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 2.3 | 9.4 | GO:0009804 | coumarin metabolic process(GO:0009804) |
| 2.3 | 11.6 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
| 2.3 | 37.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 2.3 | 2.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 2.3 | 9.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 2.3 | 9.3 | GO:0009155 | purine deoxyribonucleotide catabolic process(GO:0009155) |
| 2.3 | 11.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 2.3 | 30.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 2.3 | 4.6 | GO:0051923 | sulfation(GO:0051923) |
| 2.3 | 18.3 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 2.3 | 20.5 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 2.3 | 79.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 2.3 | 79.8 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 2.3 | 18.2 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
| 2.3 | 11.4 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
| 2.3 | 22.7 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 2.3 | 20.3 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 2.3 | 2.3 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
| 2.2 | 18.0 | GO:0097106 | postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 2.2 | 2.2 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
| 2.2 | 11.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 2.2 | 4.5 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 2.2 | 15.6 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 2.2 | 69.0 | GO:0006198 | cAMP catabolic process(GO:0006198) |
| 2.2 | 15.5 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
| 2.2 | 6.6 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
| 2.2 | 2.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
| 2.2 | 59.5 | GO:0010107 | potassium ion import(GO:0010107) |
| 2.2 | 13.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 2.2 | 6.6 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
| 2.2 | 2.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 2.2 | 2.2 | GO:1901343 | negative regulation of vasculature development(GO:1901343) |
| 2.2 | 24.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 2.2 | 15.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 2.2 | 15.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 2.2 | 21.7 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 2.2 | 28.1 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 2.2 | 15.1 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 2.2 | 6.5 | GO:0070317 | regulation of G0 to G1 transition(GO:0070316) negative regulation of G0 to G1 transition(GO:0070317) |
| 2.2 | 4.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 2.2 | 10.8 | GO:0080009 | mRNA methylation(GO:0080009) |
| 2.1 | 2.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
| 2.1 | 30.0 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
| 2.1 | 10.7 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 2.1 | 6.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 2.1 | 14.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 2.1 | 8.5 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 2.1 | 4.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 2.1 | 10.6 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 2.1 | 10.6 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 2.1 | 8.5 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 2.1 | 16.9 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 2.1 | 8.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 2.1 | 6.3 | GO:0034201 | response to oleic acid(GO:0034201) |
| 2.1 | 8.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 2.1 | 6.3 | GO:1900075 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 2.1 | 4.2 | GO:0070781 | response to biotin(GO:0070781) |
| 2.1 | 35.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 2.1 | 2.1 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) |
| 2.1 | 25.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 2.1 | 6.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 2.1 | 8.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 2.1 | 4.1 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 2.1 | 10.3 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 2.1 | 2.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 2.0 | 4.1 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 2.0 | 6.1 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 2.0 | 40.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 2.0 | 20.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
| 2.0 | 6.1 | GO:1902108 | regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 2.0 | 12.1 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 2.0 | 4.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 2.0 | 10.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 2.0 | 12.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 2.0 | 14.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 2.0 | 10.1 | GO:0001825 | blastocyst formation(GO:0001825) |
| 2.0 | 12.0 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
| 2.0 | 2.0 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 2.0 | 2.0 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
| 2.0 | 6.0 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 2.0 | 11.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 2.0 | 5.9 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 2.0 | 2.0 | GO:0015793 | glycerol transport(GO:0015793) |
| 2.0 | 11.8 | GO:0002784 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
| 2.0 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 2.0 | 159.5 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 2.0 | 7.8 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 2.0 | 7.8 | GO:0001757 | somite specification(GO:0001757) |
| 1.9 | 40.9 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 1.9 | 13.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 1.9 | 7.8 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 1.9 | 3.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 1.9 | 17.4 | GO:0015747 | urate transport(GO:0015747) |
| 1.9 | 19.4 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 1.9 | 13.6 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 1.9 | 11.6 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 1.9 | 3.8 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 1.9 | 245.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.9 | 11.5 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 1.9 | 3.8 | GO:0060023 | soft palate development(GO:0060023) |
| 1.9 | 1.9 | GO:0048296 | regulation of isotype switching to IgA isotypes(GO:0048296) |
| 1.9 | 3.8 | GO:0019755 | urea transport(GO:0015840) one-carbon compound transport(GO:0019755) |
| 1.9 | 20.9 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
| 1.9 | 3.8 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
| 1.9 | 11.4 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 1.9 | 7.6 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.9 | 1.9 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
| 1.9 | 5.6 | GO:1904180 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 1.9 | 3.8 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 1.9 | 5.6 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 1.9 | 5.6 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 1.9 | 7.5 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.9 | 7.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 1.9 | 5.6 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 1.9 | 13.0 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
| 1.9 | 3.7 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 1.8 | 24.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 1.8 | 11.0 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 1.8 | 11.0 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 1.8 | 7.3 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.8 | 7.2 | GO:0090009 | primitive streak formation(GO:0090009) |
| 1.8 | 10.8 | GO:0040020 | regulation of meiotic nuclear division(GO:0040020) |
| 1.8 | 9.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 1.8 | 7.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 1.8 | 21.5 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 1.8 | 3.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 1.8 | 1.8 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 1.8 | 5.4 | GO:1904029 | regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 1.8 | 19.6 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 1.8 | 16.0 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 1.8 | 5.3 | GO:0042748 | optic nerve structural organization(GO:0021633) circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 1.8 | 7.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 1.8 | 8.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 1.8 | 3.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 1.8 | 1.8 | GO:0002445 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
| 1.8 | 26.4 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
| 1.8 | 8.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 1.8 | 38.5 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
| 1.8 | 8.8 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 1.7 | 6.9 | GO:0046689 | response to mercury ion(GO:0046689) |
| 1.7 | 13.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 1.7 | 8.7 | GO:0002396 | MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) |
| 1.7 | 27.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 1.7 | 10.4 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
| 1.7 | 8.6 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 1.7 | 5.2 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.7 | 6.8 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
| 1.7 | 8.6 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
| 1.7 | 5.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 1.7 | 27.2 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 1.7 | 8.5 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 1.7 | 39.1 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
| 1.7 | 3.4 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 1.7 | 8.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 1.7 | 1.7 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 1.7 | 1.7 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.7 | 8.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
| 1.7 | 13.4 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 1.7 | 20.1 | GO:0019317 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 1.7 | 3.3 | GO:0060058 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.7 | 3.3 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 1.7 | 5.0 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 1.7 | 13.2 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 1.6 | 23.1 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
| 1.6 | 4.9 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.6 | 9.8 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 1.6 | 16.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 1.6 | 4.9 | GO:0002545 | microglial cell activation involved in immune response(GO:0002282) chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 1.6 | 4.8 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
| 1.6 | 11.3 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 1.6 | 4.8 | GO:0097178 | ruffle assembly(GO:0097178) |
| 1.6 | 11.2 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
| 1.6 | 14.4 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 1.6 | 12.8 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
| 1.6 | 4.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.6 | 60.7 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 1.6 | 6.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 1.6 | 4.8 | GO:0061101 | noradrenergic neuron differentiation(GO:0003357) noradrenergic neuron development(GO:0003358) neuroendocrine cell differentiation(GO:0061101) |
| 1.6 | 20.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 1.6 | 34.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 1.6 | 4.7 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 1.6 | 9.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 1.6 | 4.7 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
| 1.6 | 3.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 1.6 | 7.8 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 1.6 | 3.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) isoleucine catabolic process(GO:0006550) |
| 1.5 | 6.2 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 1.5 | 3.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.5 | 4.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 1.5 | 9.2 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
| 1.5 | 51.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 1.5 | 4.6 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 1.5 | 9.1 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 1.5 | 7.6 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 1.5 | 4.5 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
| 1.5 | 16.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 1.5 | 7.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
| 1.5 | 28.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
| 1.5 | 4.5 | GO:0008272 | sulfate transport(GO:0008272) |
| 1.5 | 7.5 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
| 1.5 | 4.5 | GO:0098935 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 1.5 | 6.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 1.5 | 6.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 1.5 | 11.9 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 1.5 | 8.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 1.5 | 8.9 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 1.5 | 6.0 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 1.5 | 4.5 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
| 1.5 | 3.0 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 1.5 | 4.5 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 1.5 | 7.4 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 1.5 | 4.4 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
| 1.5 | 8.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 1.5 | 7.4 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 1.5 | 5.9 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 1.5 | 5.9 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 1.5 | 8.8 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.5 | 2.9 | GO:0048102 | autophagic cell death(GO:0048102) |
| 1.4 | 8.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 1.4 | 7.2 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 1.4 | 1.4 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 1.4 | 4.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.4 | 1.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 1.4 | 8.5 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 1.4 | 4.2 | GO:0060736 | prostate gland growth(GO:0060736) |
| 1.4 | 5.6 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 1.4 | 61.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 1.4 | 23.8 | GO:0021854 | hypothalamus development(GO:0021854) |
| 1.4 | 89.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 1.4 | 4.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.4 | 16.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 1.4 | 4.2 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 1.4 | 11.1 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 1.4 | 1.4 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 1.4 | 11.1 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 1.4 | 4.2 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 1.4 | 4.1 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 1.4 | 4.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 1.4 | 8.2 | GO:0051321 | meiotic cell cycle(GO:0051321) |
| 1.4 | 2.7 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) response to fluoride(GO:1902617) |
| 1.4 | 10.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
| 1.4 | 6.8 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 1.4 | 9.5 | GO:0070445 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.4 | 4.1 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 1.4 | 5.4 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 1.3 | 5.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 1.3 | 1.3 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 1.3 | 4.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 1.3 | 20.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 1.3 | 8.1 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.3 | 5.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 1.3 | 8.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.3 | 26.8 | GO:0097503 | sialylation(GO:0097503) |
| 1.3 | 4.0 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 1.3 | 6.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 1.3 | 5.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 1.3 | 6.7 | GO:0006265 | DNA topological change(GO:0006265) |
| 1.3 | 9.3 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 1.3 | 26.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 1.3 | 2.7 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
| 1.3 | 1.3 | GO:0008037 | cell recognition(GO:0008037) |
| 1.3 | 4.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
| 1.3 | 5.3 | GO:0014850 | response to muscle activity(GO:0014850) |
| 1.3 | 4.0 | GO:0003431 | growth plate cartilage chondrocyte growth(GO:0003430) growth plate cartilage chondrocyte development(GO:0003431) |
| 1.3 | 6.6 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 1.3 | 21.0 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.3 | 2.6 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
| 1.3 | 6.5 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 1.3 | 7.8 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
| 1.3 | 20.8 | GO:0006874 | cellular calcium ion homeostasis(GO:0006874) |
| 1.3 | 15.5 | GO:0051384 | response to glucocorticoid(GO:0051384) |
| 1.3 | 6.5 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.3 | 3.9 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 1.3 | 5.1 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 1.3 | 18.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 1.3 | 28.2 | GO:0097502 | mannosylation(GO:0097502) |
| 1.3 | 2.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 1.3 | 5.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 1.3 | 7.6 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 1.3 | 21.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
| 1.3 | 1.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 1.3 | 7.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 1.3 | 5.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 1.3 | 2.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 1.2 | 8.7 | GO:0006833 | water transport(GO:0006833) |
| 1.2 | 2.5 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 1.2 | 1.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
| 1.2 | 8.7 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
| 1.2 | 13.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
| 1.2 | 4.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
| 1.2 | 6.2 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 1.2 | 7.4 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 1.2 | 6.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 1.2 | 20.9 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 1.2 | 35.6 | GO:0006813 | potassium ion transport(GO:0006813) |
| 1.2 | 13.5 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 1.2 | 7.3 | GO:0016322 | neuron remodeling(GO:0016322) |
| 1.2 | 10.9 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 1.2 | 12.1 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 1.2 | 7.1 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 1.2 | 3.6 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 1.2 | 7.1 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 1.2 | 8.3 | GO:2001222 | regulation of neuron migration(GO:2001222) |
| 1.2 | 3.6 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
| 1.2 | 4.7 | GO:0045836 | positive regulation of meiotic nuclear division(GO:0045836) |
| 1.2 | 5.9 | GO:0015824 | proline transport(GO:0015824) |
| 1.2 | 3.6 | GO:0052422 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 1.2 | 13.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.2 | 14.2 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 1.2 | 3.5 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 1.2 | 1.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 1.2 | 2.3 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 1.2 | 3.5 | GO:0035640 | exploration behavior(GO:0035640) |
| 1.2 | 1.2 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) response to interleukin-15(GO:0070672) cellular response to interleukin-15(GO:0071350) |
| 1.2 | 3.5 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 1.2 | 2.3 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 1.2 | 7.0 | GO:0035082 | axoneme assembly(GO:0035082) |
| 1.2 | 3.5 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 1.2 | 5.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 1.2 | 9.3 | GO:0016926 | protein desumoylation(GO:0016926) |
| 1.2 | 4.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 1.2 | 1.2 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 1.1 | 6.9 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) positive regulation of cardiac muscle contraction(GO:0060452) |
| 1.1 | 4.6 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
| 1.1 | 3.4 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
| 1.1 | 2.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
| 1.1 | 20.5 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
| 1.1 | 11.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 1.1 | 15.9 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
| 1.1 | 4.5 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 1.1 | 7.9 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 1.1 | 5.6 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 1.1 | 5.6 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 1.1 | 4.5 | GO:0048749 | compound eye development(GO:0048749) |
| 1.1 | 14.6 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 1.1 | 28.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 1.1 | 9.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 1.1 | 1.1 | GO:0018377 | protein myristoylation(GO:0018377) |
| 1.1 | 4.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.1 | 3.3 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
| 1.1 | 10.0 | GO:0051026 | chiasma assembly(GO:0051026) |
| 1.1 | 7.8 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 1.1 | 4.4 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
| 1.1 | 1.1 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
| 1.1 | 2.2 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) |
| 1.1 | 11.0 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 1.1 | 8.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 1.1 | 4.4 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 1.1 | 8.8 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 1.1 | 1.1 | GO:0032571 | response to vitamin K(GO:0032571) |
| 1.1 | 2.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 1.1 | 3.3 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 1.1 | 7.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 1.1 | 6.6 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
| 1.1 | 4.4 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 1.1 | 2.2 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 1.1 | 10.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 1.1 | 4.3 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 1.1 | 8.6 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 1.1 | 6.4 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 1.1 | 4.3 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
| 1.1 | 1.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
| 1.1 | 10.6 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 1.1 | 2.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
| 1.1 | 3.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 1.1 | 12.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 1.0 | 8.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 1.0 | 11.5 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 1.0 | 9.4 | GO:0015671 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 1.0 | 5.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.0 | 21.8 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 1.0 | 5.2 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 1.0 | 12.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 1.0 | 3.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.0 | 5.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 1.0 | 4.1 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.0 | 38.2 | GO:0030279 | negative regulation of ossification(GO:0030279) |
| 1.0 | 132.6 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
| 1.0 | 4.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 1.0 | 3.1 | GO:0034699 | response to luteinizing hormone(GO:0034699) luteinizing hormone signaling pathway(GO:0042700) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 1.0 | 5.1 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 1.0 | 3.1 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
| 1.0 | 8.1 | GO:0006475 | internal protein amino acid acetylation(GO:0006475) |
| 1.0 | 4.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 1.0 | 23.2 | GO:0060612 | adipose tissue development(GO:0060612) |
| 1.0 | 15.1 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 1.0 | 2.0 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 1.0 | 11.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 1.0 | 6.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 1.0 | 16.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 1.0 | 5.0 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.0 | 74.7 | GO:0007422 | peripheral nervous system development(GO:0007422) |
| 1.0 | 6.0 | GO:1990822 | basic amino acid transmembrane transport(GO:1990822) |
| 1.0 | 13.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 1.0 | 42.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 1.0 | 8.9 | GO:0070723 | response to sterol(GO:0036314) response to cholesterol(GO:0070723) |
| 1.0 | 3.0 | GO:1902896 | terminal web assembly(GO:1902896) |
| 1.0 | 4.9 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.0 | 20.7 | GO:0019226 | transmission of nerve impulse(GO:0019226) |
| 1.0 | 6.9 | GO:0015732 | prostaglandin transport(GO:0015732) |
| 1.0 | 7.8 | GO:0031643 | positive regulation of myelination(GO:0031643) |
| 1.0 | 29.3 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 1.0 | 9.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 1.0 | 3.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 1.0 | 3.9 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 1.0 | 5.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 1.0 | 5.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 1.0 | 2.9 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 1.0 | 6.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 1.0 | 13.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 1.0 | 9.7 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 1.0 | 6.8 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 1.0 | 1.9 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 1.0 | 1.9 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 1.0 | 6.7 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) negative regulation of cell volume(GO:0045794) |
| 1.0 | 1.9 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.9 | 6.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.9 | 5.7 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.9 | 3.8 | GO:0036016 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.9 | 2.8 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.9 | 2.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.9 | 0.9 | GO:0048754 | branching morphogenesis of an epithelial tube(GO:0048754) |
| 0.9 | 4.6 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.9 | 2.8 | GO:0072017 | distal tubule development(GO:0072017) |
| 0.9 | 5.5 | GO:0072337 | modified amino acid transport(GO:0072337) |
| 0.9 | 23.8 | GO:0008089 | anterograde axonal transport(GO:0008089) |
| 0.9 | 1.8 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.9 | 4.5 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.9 | 1.8 | GO:0008105 | asymmetric protein localization(GO:0008105) |
| 0.9 | 19.7 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
| 0.9 | 44.7 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.9 | 4.4 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.9 | 7.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
| 0.9 | 2.6 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.9 | 44.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.9 | 3.5 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.9 | 3.5 | GO:0001696 | gastric acid secretion(GO:0001696) |
| 0.9 | 7.0 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
| 0.9 | 5.3 | GO:0050708 | regulation of protein secretion(GO:0050708) |
| 0.9 | 16.6 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.9 | 2.6 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
| 0.9 | 3.5 | GO:1902731 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.9 | 1.7 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.9 | 6.0 | GO:0015871 | choline transport(GO:0015871) |
| 0.9 | 2.6 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.9 | 41.1 | GO:0006469 | negative regulation of protein kinase activity(GO:0006469) |
| 0.9 | 6.0 | GO:0044146 | negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.9 | 2.6 | GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion(GO:0010881) |
| 0.9 | 3.4 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
| 0.8 | 27.1 | GO:1901800 | positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.8 | 6.8 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.8 | 2.5 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.8 | 9.2 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
| 0.8 | 4.2 | GO:0007512 | adult heart development(GO:0007512) |
| 0.8 | 5.0 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.8 | 5.0 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.8 | 33.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.8 | 2.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
| 0.8 | 17.2 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.8 | 5.7 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
| 0.8 | 8.2 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.8 | 13.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.8 | 1.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.8 | 8.0 | GO:0036065 | fucosylation(GO:0036065) |
| 0.8 | 3.9 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.8 | 12.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.8 | 7.0 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.8 | 0.8 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.8 | 2.3 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
| 0.8 | 4.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) cytidine to uridine editing(GO:0016554) |
| 0.8 | 6.1 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
| 0.8 | 0.8 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 0.8 | 4.6 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.8 | 5.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.8 | 0.8 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 0.8 | 5.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.8 | 6.8 | GO:0043551 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) |
| 0.8 | 3.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.8 | 8.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.8 | 3.8 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.8 | 2.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
| 0.7 | 6.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.7 | 5.2 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.7 | 4.5 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.7 | 14.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.7 | 4.4 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.7 | 8.1 | GO:0051181 | cofactor transport(GO:0051181) |
| 0.7 | 3.0 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
| 0.7 | 9.6 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.7 | 19.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 0.7 | 2.2 | GO:1903844 | regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
| 0.7 | 1.5 | GO:0001660 | fever generation(GO:0001660) |
| 0.7 | 4.4 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.7 | 23.9 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.7 | 12.3 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.7 | 1.4 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) regulation of serine-type peptidase activity(GO:1902571) |
| 0.7 | 0.7 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.7 | 10.7 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.7 | 7.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.7 | 6.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.7 | 19.0 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.7 | 4.2 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
| 0.7 | 3.5 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.7 | 9.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.7 | 42.6 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.7 | 2.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.7 | 2.8 | GO:0072501 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.7 | 3.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.7 | 13.8 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
| 0.7 | 4.8 | GO:0006983 | ER overload response(GO:0006983) |
| 0.7 | 6.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.7 | 7.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.7 | 8.2 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.7 | 4.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.7 | 8.8 | GO:0070664 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) negative regulation of leukocyte proliferation(GO:0070664) |
| 0.7 | 2.7 | GO:0045072 | regulation of interferon-gamma biosynthetic process(GO:0045072) |
| 0.7 | 2.0 | GO:2000351 | regulation of endothelial cell apoptotic process(GO:2000351) |
| 0.7 | 4.0 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.7 | 8.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.7 | 4.0 | GO:0070633 | transepithelial chloride transport(GO:0030321) transepithelial transport(GO:0070633) |
| 0.7 | 4.0 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.7 | 2.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.6 | 7.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.6 | 5.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.6 | 1.9 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
| 0.6 | 10.9 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.6 | 1.3 | GO:1903726 | negative regulation of phospholipid metabolic process(GO:1903726) |
| 0.6 | 4.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.6 | 17.8 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.6 | 1.9 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.6 | 11.3 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.6 | 8.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.6 | 16.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.6 | 7.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
| 0.6 | 1.9 | GO:1902414 | protein localization to cell junction(GO:1902414) |
| 0.6 | 3.7 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.6 | 1.2 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
| 0.6 | 12.1 | GO:0003407 | neural retina development(GO:0003407) |
| 0.6 | 2.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
| 0.6 | 1.8 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.6 | 3.0 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
| 0.6 | 3.0 | GO:0003351 | epithelial cilium movement(GO:0003351) |
| 0.6 | 5.3 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.6 | 32.9 | GO:0007586 | digestion(GO:0007586) |
| 0.6 | 2.9 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.6 | 1.7 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 0.6 | 8.0 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.6 | 4.0 | GO:0060292 | long term synaptic depression(GO:0060292) |
| 0.6 | 2.3 | GO:0050798 | activated T cell proliferation(GO:0050798) |
| 0.6 | 17.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.6 | 1.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.6 | 16.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.6 | 2.8 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.6 | 1.1 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) |
| 0.6 | 1.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.6 | 1.1 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.6 | 3.9 | GO:0034505 | tooth mineralization(GO:0034505) |
| 0.6 | 1.7 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.5 | 3.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.5 | 1.6 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.5 | 6.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.5 | 1.6 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
| 0.5 | 2.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.5 | 18.6 | GO:1901998 | toxin transport(GO:1901998) |
| 0.5 | 6.5 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
| 0.5 | 6.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.5 | 5.9 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.5 | 2.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.5 | 2.1 | GO:0030010 | establishment of cell polarity(GO:0030010) |
| 0.5 | 1.6 | GO:0007350 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.5 | 3.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.5 | 1.0 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.5 | 2.1 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.5 | 3.1 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.5 | 1.5 | GO:0071380 | cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.5 | 9.2 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.5 | 1.0 | GO:0032095 | regulation of response to food(GO:0032095) |
| 0.5 | 2.0 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.5 | 17.8 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
| 0.5 | 1.5 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.5 | 2.5 | GO:0046785 | microtubule polymerization(GO:0046785) |
| 0.5 | 8.0 | GO:0007614 | short-term memory(GO:0007614) |
| 0.5 | 12.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.5 | 2.5 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.5 | 8.4 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.5 | 8.4 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.5 | 14.2 | GO:0097553 | calcium ion transmembrane import into cytosol(GO:0097553) calcium ion import into cytosol(GO:1902656) |
| 0.5 | 13.2 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.5 | 3.4 | GO:0006513 | protein monoubiquitination(GO:0006513) |
| 0.5 | 3.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.5 | 2.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.5 | 6.7 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.5 | 0.5 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.5 | 3.8 | GO:0002517 | T cell tolerance induction(GO:0002517) |
| 0.5 | 1.0 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 0.5 | 1.4 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.5 | 2.4 | GO:1904590 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
| 0.5 | 0.9 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.5 | 1.4 | GO:0072402 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.5 | 1.9 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.5 | 2.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.5 | 2.8 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.5 | 3.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.5 | 3.2 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.5 | 15.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.5 | 0.9 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
| 0.5 | 3.6 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.5 | 5.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) hindlimb morphogenesis(GO:0035137) |
| 0.5 | 5.9 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
| 0.4 | 25.7 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
| 0.4 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.4 | 1.3 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.4 | 8.8 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.4 | 0.9 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.4 | 3.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.4 | 1.7 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.4 | 1.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.4 | 2.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.4 | 2.9 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
| 0.4 | 4.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.4 | 3.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.4 | 1.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.4 | 217.9 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
| 0.4 | 2.0 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.4 | 0.8 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.4 | 4.1 | GO:0046324 | regulation of glucose import(GO:0046324) |
| 0.4 | 2.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.4 | 3.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.4 | 1.6 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.4 | 1.6 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.4 | 6.3 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.4 | 1.6 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.4 | 1.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.4 | 0.4 | GO:0033083 | regulation of immature T cell proliferation(GO:0033083) negative regulation of immature T cell proliferation(GO:0033087) |
| 0.4 | 0.4 | GO:0044036 | cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.4 | 1.5 | GO:0009624 | response to nematode(GO:0009624) |
| 0.4 | 6.5 | GO:0005979 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
| 0.4 | 1.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.4 | 3.2 | GO:0030324 | lung development(GO:0030324) |
| 0.3 | 1.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.3 | 4.1 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.3 | 2.1 | GO:0009798 | axis specification(GO:0009798) |
| 0.3 | 4.4 | GO:0010863 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
| 0.3 | 1.7 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.3 | 3.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.3 | 0.7 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
| 0.3 | 2.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.3 | 5.2 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.3 | 2.3 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.3 | 9.1 | GO:0007416 | synapse assembly(GO:0007416) |
| 0.3 | 1.0 | GO:0032350 | regulation of hormone metabolic process(GO:0032350) |
| 0.3 | 1.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.3 | 1.6 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 1.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.3 | 2.5 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.3 | 5.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.3 | 1.6 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 5.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 | 2.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.3 | 3.4 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.3 | 0.9 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 | 2.4 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.3 | 0.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
| 0.3 | 0.9 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.3 | 0.9 | GO:0051197 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.3 | 2.6 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.3 | 5.1 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
| 0.3 | 1.1 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.3 | 3.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.3 | 0.8 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.3 | 1.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 0.3 | 2.5 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
| 0.3 | 2.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.3 | 0.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.3 | 6.5 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.3 | 1.1 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.3 | 0.8 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 0.3 | 3.2 | GO:0009880 | embryonic pattern specification(GO:0009880) |
| 0.3 | 1.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.3 | 1.6 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.3 | 2.1 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.3 | 6.3 | GO:0021549 | cerebellum development(GO:0021549) |
| 0.3 | 2.3 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.3 | 3.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
| 0.3 | 3.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.3 | 1.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
| 0.3 | 1.8 | GO:0033151 | V(D)J recombination(GO:0033151) |
| 0.2 | 8.5 | GO:0003279 | cardiac septum development(GO:0003279) |
| 0.2 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.2 | 5.7 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 0.2 | 0.7 | GO:0031349 | positive regulation of defense response(GO:0031349) |
| 0.2 | 4.0 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.2 | 1.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.2 | 1.6 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.2 | 0.4 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.2 | 13.6 | GO:0007286 | spermatid development(GO:0007286) |
| 0.2 | 1.1 | GO:0090128 | regulation of synapse maturation(GO:0090128) positive regulation of synapse maturation(GO:0090129) |
| 0.2 | 0.6 | GO:0007210 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) serotonin receptor signaling pathway(GO:0007210) |
| 0.2 | 8.1 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) peptidyl-serine modification(GO:0018209) |
| 0.2 | 0.2 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 0.2 | 1.5 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
| 0.2 | 1.7 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.2 | 4.6 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 0.2 | 2.7 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.2 | 2.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.2 | 0.6 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.2 | 0.8 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.2 | 1.4 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.2 | 2.0 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.2 | 1.2 | GO:0001755 | neural crest cell migration(GO:0001755) |
| 0.2 | 2.5 | GO:0045778 | positive regulation of ossification(GO:0045778) |
| 0.2 | 0.4 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.2 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.2 | 0.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.2 | 23.7 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.2 | 1.9 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.2 | 0.6 | GO:0071711 | basement membrane organization(GO:0071711) |
| 0.2 | 0.9 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 0.4 | GO:0048278 | vesicle docking(GO:0048278) |
| 0.2 | 0.9 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.2 | 0.4 | GO:0048593 | camera-type eye morphogenesis(GO:0048593) |
| 0.2 | 0.4 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 0.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.2 | 1.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.2 | 0.5 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
| 0.2 | 1.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.2 | 0.9 | GO:0042789 | mRNA transcription(GO:0009299) mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.2 | 3.8 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.2 | 0.5 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 | 1.2 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.2 | 1.5 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 1.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.2 | 0.5 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.2 | 0.5 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.2 | 0.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 | 0.1 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 | 2.8 | GO:0009581 | detection of external stimulus(GO:0009581) detection of abiotic stimulus(GO:0009582) |
| 0.1 | 0.8 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
| 0.1 | 0.4 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.1 | 1.2 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 0.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 3.8 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
| 0.1 | 0.5 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 | 0.5 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 0.4 | GO:0018342 | protein prenylation(GO:0018342) protein geranylgeranylation(GO:0018344) prenylation(GO:0097354) |
| 0.1 | 0.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.6 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
| 0.1 | 0.1 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.1 | 3.4 | GO:0048024 | regulation of mRNA splicing, via spliceosome(GO:0048024) |
| 0.1 | 2.0 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
| 0.1 | 0.6 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 | 1.2 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 | 5.0 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.1 | 1.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.3 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
| 0.1 | 0.5 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.1 | 0.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.1 | 0.4 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
| 0.1 | 0.7 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.1 | 0.6 | GO:0000266 | mitochondrial fission(GO:0000266) |
| 0.1 | 0.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.1 | 0.1 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
| 0.1 | 0.2 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.1 | 0.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 0.8 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.1 | 0.4 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 0.3 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.1 | 0.5 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 | 0.3 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 0.1 | GO:1901655 | cellular response to ketone(GO:1901655) |
| 0.1 | 0.2 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.1 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.0 | 1.7 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
| 0.0 | 0.8 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.0 | 0.3 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.0 | 0.2 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 | 0.3 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 | 0.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 | 0.6 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 | 0.0 | GO:0035315 | hair cell differentiation(GO:0035315) |
| 0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.0 | 0.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 21.5 | 85.9 | GO:0070695 | FHF complex(GO:0070695) |
| 15.2 | 75.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 13.7 | 41.0 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 12.0 | 95.8 | GO:0045179 | apical cortex(GO:0045179) |
| 11.6 | 34.8 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 11.2 | 33.7 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 11.0 | 44.0 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 10.4 | 93.9 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 10.3 | 41.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 10.3 | 61.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 9.7 | 77.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 9.7 | 48.4 | GO:0071546 | pi-body(GO:0071546) |
| 9.1 | 45.5 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 9.0 | 9.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 8.9 | 8.9 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
| 8.7 | 60.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 7.8 | 195.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 7.5 | 75.1 | GO:0070938 | contractile ring(GO:0070938) |
| 6.8 | 6.8 | GO:0043291 | RAVE complex(GO:0043291) |
| 6.7 | 93.6 | GO:0042583 | chromaffin granule(GO:0042583) |
| 6.6 | 39.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 6.4 | 103.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 6.3 | 43.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 6.2 | 24.8 | GO:0060203 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 6.1 | 30.7 | GO:0036128 | CatSper complex(GO:0036128) |
| 5.7 | 17.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 4.8 | 29.0 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 4.6 | 4.6 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 4.6 | 13.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 4.5 | 9.0 | GO:0044305 | calyx of Held(GO:0044305) |
| 4.4 | 93.3 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 4.3 | 12.8 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 4.2 | 34.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 4.2 | 4.2 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 4.2 | 16.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 4.2 | 37.4 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 4.1 | 16.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 3.9 | 7.9 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 3.9 | 19.4 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 3.9 | 38.6 | GO:0097449 | astrocyte projection(GO:0097449) |
| 3.8 | 11.5 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 3.8 | 7.6 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 3.7 | 44.0 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 3.6 | 10.7 | GO:0016460 | myosin II complex(GO:0016460) |
| 3.6 | 7.1 | GO:0034657 | GID complex(GO:0034657) |
| 3.6 | 14.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 3.5 | 28.2 | GO:0043203 | axon hillock(GO:0043203) |
| 3.5 | 41.4 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 3.4 | 13.6 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 3.4 | 272.2 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 3.3 | 16.7 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 3.3 | 13.3 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) intrinsic component of vacuolar membrane(GO:0031310) |
| 3.3 | 16.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 3.2 | 25.7 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 3.2 | 63.1 | GO:0005861 | troponin complex(GO:0005861) |
| 3.1 | 231.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 3.1 | 62.2 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 3.1 | 18.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 3.1 | 15.4 | GO:0045298 | tubulin complex(GO:0045298) |
| 3.0 | 104.7 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 3.0 | 32.7 | GO:0031045 | dense core granule(GO:0031045) |
| 2.9 | 93.5 | GO:0030057 | desmosome(GO:0030057) |
| 2.9 | 5.8 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 2.8 | 5.7 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 2.8 | 39.7 | GO:0033270 | paranode region of axon(GO:0033270) |
| 2.8 | 28.0 | GO:0044327 | dendritic spine head(GO:0044327) |
| 2.8 | 5.6 | GO:0030662 | coated vesicle membrane(GO:0030662) |
| 2.8 | 16.6 | GO:0032280 | symmetric synapse(GO:0032280) |
| 2.7 | 35.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 2.7 | 13.5 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 2.6 | 7.9 | GO:0098536 | deuterosome(GO:0098536) |
| 2.6 | 28.8 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 2.6 | 10.3 | GO:0043293 | apoptosome(GO:0043293) |
| 2.6 | 10.2 | GO:1990745 | EARP complex(GO:1990745) |
| 2.5 | 20.3 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
| 2.5 | 22.8 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 2.5 | 7.6 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 2.5 | 72.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 2.5 | 34.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 2.5 | 17.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 2.4 | 7.2 | GO:0044609 | DBIRD complex(GO:0044609) |
| 2.4 | 7.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 2.3 | 32.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 2.3 | 32.6 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 2.3 | 4.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 2.3 | 18.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 2.3 | 49.7 | GO:0031528 | microvillus membrane(GO:0031528) |
| 2.3 | 6.8 | GO:0036398 | TCR signalosome(GO:0036398) |
| 2.2 | 15.7 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 2.2 | 38.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 2.2 | 6.7 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 2.2 | 15.7 | GO:1990635 | proximal dendrite(GO:1990635) |
| 2.2 | 4.4 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
| 2.2 | 13.3 | GO:0032807 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) DNA ligase IV complex(GO:0032807) |
| 2.2 | 13.0 | GO:0097427 | microtubule bundle(GO:0097427) |
| 2.1 | 8.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 2.1 | 6.3 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 2.1 | 66.5 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
| 2.1 | 8.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 2.1 | 8.2 | GO:0005713 | recombination nodule(GO:0005713) |
| 2.1 | 102.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 2.0 | 8.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 2.0 | 9.9 | GO:0089701 | U2AF(GO:0089701) |
| 1.9 | 15.1 | GO:0031674 | I band(GO:0031674) |
| 1.9 | 22.6 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 1.9 | 15.1 | GO:0030478 | actin cap(GO:0030478) |
| 1.9 | 93.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 1.9 | 11.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 1.8 | 18.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 1.8 | 14.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 1.8 | 25.4 | GO:0005858 | axonemal dynein complex(GO:0005858) |
| 1.8 | 43.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 1.8 | 41.1 | GO:0043235 | receptor complex(GO:0043235) |
| 1.8 | 7.1 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 1.8 | 12.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.7 | 17.4 | GO:0097433 | dense body(GO:0097433) |
| 1.7 | 5.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 1.7 | 12.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 1.7 | 17.2 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.7 | 10.2 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 1.7 | 16.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 1.7 | 5.0 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 1.7 | 8.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.6 | 6.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 1.6 | 63.0 | GO:0034707 | chloride channel complex(GO:0034707) |
| 1.6 | 33.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.6 | 35.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 1.6 | 55.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 1.6 | 7.9 | GO:0044447 | axoneme part(GO:0044447) |
| 1.6 | 12.6 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 1.5 | 21.7 | GO:0001741 | XY body(GO:0001741) |
| 1.5 | 4.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 1.5 | 10.8 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 1.5 | 16.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.5 | 39.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 1.5 | 17.9 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 1.4 | 7.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 1.4 | 5.8 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 1.4 | 4.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 1.4 | 11.4 | GO:0033267 | axon part(GO:0033267) |
| 1.4 | 8.4 | GO:0005883 | neurofilament(GO:0005883) |
| 1.4 | 7.0 | GO:0032021 | NELF complex(GO:0032021) |
| 1.4 | 23.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
| 1.4 | 12.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 1.4 | 8.3 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.4 | 20.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.4 | 19.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 1.4 | 5.5 | GO:0098576 | lumenal side of membrane(GO:0098576) |
| 1.4 | 25.7 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
| 1.3 | 137.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 1.3 | 10.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 1.3 | 26.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 1.3 | 7.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.3 | 6.5 | GO:0030673 | axolemma(GO:0030673) |
| 1.3 | 5.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 1.3 | 5.1 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) catenin-TCF7L2 complex(GO:0071664) |
| 1.3 | 35.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 1.3 | 10.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 1.2 | 47.5 | GO:0030315 | T-tubule(GO:0030315) |
| 1.2 | 33.7 | GO:0034451 | centriolar satellite(GO:0034451) |
| 1.2 | 7.5 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 1.2 | 7.4 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 1.2 | 21.1 | GO:0042627 | chylomicron(GO:0042627) |
| 1.2 | 28.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 1.2 | 131.3 | GO:0043204 | perikaryon(GO:0043204) |
| 1.2 | 2.4 | GO:0001740 | Barr body(GO:0001740) |
| 1.2 | 6.0 | GO:0072687 | meiotic spindle(GO:0072687) |
| 1.2 | 14.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 1.2 | 10.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.2 | 11.7 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 1.2 | 15.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 1.2 | 10.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 1.2 | 18.6 | GO:0005922 | connexon complex(GO:0005922) |
| 1.2 | 5.8 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 1.1 | 28.7 | GO:0008305 | integrin complex(GO:0008305) |
| 1.1 | 47.4 | GO:0097546 | ciliary base(GO:0097546) |
| 1.1 | 5.6 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 1.1 | 7.8 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 1.1 | 11.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 1.1 | 5.6 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 1.1 | 13.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.1 | 48.8 | GO:0005902 | microvillus(GO:0005902) |
| 1.1 | 5.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 1.1 | 10.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 1.1 | 13.9 | GO:0000800 | lateral element(GO:0000800) |
| 1.0 | 16.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 1.0 | 27.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 1.0 | 5.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 1.0 | 9.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 1.0 | 22.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 1.0 | 12.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 1.0 | 14.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.9 | 11.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.9 | 101.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.9 | 7.3 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
| 0.9 | 3.6 | GO:0031430 | M band(GO:0031430) |
| 0.9 | 6.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.9 | 18.7 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.9 | 2.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.9 | 3.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.9 | 6.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.8 | 52.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.8 | 0.8 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.8 | 80.7 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.8 | 4.2 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.8 | 37.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.8 | 1.6 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
| 0.8 | 2.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 0.8 | 4.1 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.8 | 26.0 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.8 | 8.1 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.8 | 3.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
| 0.8 | 9.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.8 | 29.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.8 | 0.8 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 0.8 | 9.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.8 | 6.0 | GO:0034706 | sodium channel complex(GO:0034706) |
| 0.7 | 1.5 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.7 | 36.8 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.7 | 2.2 | GO:0070081 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.7 | 105.3 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.7 | 38.1 | GO:0005811 | lipid particle(GO:0005811) |
| 0.7 | 7.9 | GO:0005921 | gap junction(GO:0005921) |
| 0.7 | 1.4 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.7 | 2.8 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.7 | 58.7 | GO:0030018 | Z disc(GO:0030018) |
| 0.7 | 14.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.7 | 7.9 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.7 | 31.4 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.6 | 2.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.6 | 86.4 | GO:0030426 | growth cone(GO:0030426) |
| 0.6 | 6.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.6 | 13.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.6 | 1.9 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.6 | 8.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.6 | 3.7 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.6 | 17.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.6 | 7.2 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.6 | 14.4 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.6 | 1.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.6 | 0.6 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.5 | 15.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.5 | 2.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.5 | 7.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.5 | 25.9 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.5 | 1.1 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.5 | 1.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.5 | 10.1 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.5 | 4.0 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.5 | 2.0 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.5 | 2.0 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.5 | 4.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.5 | 98.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.5 | 5.4 | GO:0000243 | commitment complex(GO:0000243) |
| 0.5 | 2.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.5 | 3.9 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
| 0.5 | 2.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.5 | 0.9 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.5 | 3.3 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.5 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.5 | 570.2 | GO:0005615 | extracellular space(GO:0005615) |
| 0.5 | 2.3 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
| 0.4 | 1.8 | GO:0043196 | varicosity(GO:0043196) |
| 0.4 | 2.2 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.4 | 16.9 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
| 0.4 | 2.2 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.4 | 1558.6 | GO:0031224 | intrinsic component of membrane(GO:0031224) |
| 0.4 | 1.7 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.4 | 2.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.4 | 1.2 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.4 | 1.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.4 | 2.3 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.4 | 24.9 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.3 | 2.4 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.3 | 11.1 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.3 | 104.7 | GO:0045202 | synapse(GO:0045202) |
| 0.3 | 10.1 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.3 | 2.2 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.3 | 10.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.3 | 5.9 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.3 | 1.2 | GO:0032449 | CBM complex(GO:0032449) |
| 0.3 | 2.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.3 | 6.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.3 | 2.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.3 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
| 0.3 | 1.8 | GO:0097361 | CIA complex(GO:0097361) |
| 0.2 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.2 | 1.5 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 24.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.2 | 1.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.2 | 1.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.2 | 1.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 2.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.2 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.2 | 0.5 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.1 | 1.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 0.4 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.1 | 8.3 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.1 | 0.3 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.1 | 0.4 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 2.0 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 0.1 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.0 | 0.2 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
| 0.0 | 0.9 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.0 | 0.2 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.0 | 0.1 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 0.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 20.2 | 101.0 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 17.1 | 68.3 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 16.5 | 98.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 14.1 | 42.3 | GO:0034584 | piRNA binding(GO:0034584) |
| 13.1 | 39.4 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 12.6 | 37.8 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 11.5 | 57.5 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 10.6 | 42.3 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
| 10.5 | 31.5 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 10.2 | 61.0 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 10.1 | 30.4 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 9.9 | 29.6 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 9.8 | 29.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
| 9.5 | 57.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 9.4 | 113.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 9.3 | 27.8 | GO:0004040 | amidase activity(GO:0004040) |
| 8.7 | 8.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 8.6 | 25.8 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 8.6 | 34.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 8.2 | 41.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 7.8 | 195.8 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 7.8 | 31.0 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 7.6 | 22.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 7.3 | 36.3 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 7.2 | 21.7 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 7.2 | 28.9 | GO:0008940 | nitrate reductase activity(GO:0008940) |
| 7.1 | 14.1 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 6.7 | 20.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 6.5 | 26.0 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 6.5 | 39.0 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 6.3 | 37.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 6.2 | 12.4 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 6.2 | 18.6 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 6.1 | 18.4 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 5.9 | 29.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 5.9 | 17.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 5.9 | 76.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 5.8 | 17.5 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 5.8 | 29.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 5.8 | 17.4 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 5.8 | 17.3 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 5.7 | 22.7 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 5.7 | 17.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 5.7 | 62.2 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 5.6 | 16.9 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 5.6 | 16.9 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 5.6 | 28.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 5.5 | 27.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 5.5 | 71.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 5.5 | 81.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 5.4 | 27.0 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 5.4 | 37.5 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 5.3 | 26.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 5.3 | 21.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 5.1 | 30.8 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 5.1 | 15.4 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 5.1 | 15.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 5.1 | 106.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 5.0 | 15.1 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 5.0 | 20.1 | GO:0008431 | vitamin E binding(GO:0008431) |
| 5.0 | 25.1 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 4.9 | 14.8 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 4.9 | 24.5 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
| 4.9 | 19.6 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 4.9 | 14.6 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 4.8 | 19.4 | GO:0030172 | troponin C binding(GO:0030172) |
| 4.8 | 19.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 4.8 | 19.2 | GO:0047708 | biotinidase activity(GO:0047708) |
| 4.7 | 23.3 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 4.6 | 77.8 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 4.6 | 13.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 4.6 | 18.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 4.5 | 22.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 4.5 | 22.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 4.5 | 31.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 4.5 | 22.4 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
| 4.5 | 89.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 4.4 | 31.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 4.4 | 79.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 4.4 | 17.6 | GO:0032810 | sterol response element binding(GO:0032810) |
| 4.4 | 13.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 4.3 | 26.0 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
| 4.3 | 47.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 4.3 | 43.0 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 4.2 | 16.9 | GO:0001855 | complement component C4b binding(GO:0001855) |
| 4.2 | 29.4 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 4.2 | 8.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 4.1 | 8.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 4.0 | 20.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 4.0 | 48.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 3.9 | 11.8 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 3.9 | 11.8 | GO:0070052 | collagen V binding(GO:0070052) |
| 3.9 | 11.8 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
| 3.9 | 11.7 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 3.9 | 11.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 3.9 | 19.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 3.9 | 50.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 3.9 | 31.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 3.9 | 30.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 3.8 | 3.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 3.8 | 11.4 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 3.8 | 11.4 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 3.8 | 19.0 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
| 3.8 | 15.1 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
| 3.8 | 11.3 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 3.7 | 18.5 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
| 3.7 | 22.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 3.7 | 22.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 3.7 | 11.0 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 3.6 | 10.9 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 3.6 | 10.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 3.6 | 14.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 3.6 | 10.8 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 3.6 | 92.8 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 3.5 | 17.7 | GO:0034046 | poly(G) binding(GO:0034046) |
| 3.5 | 74.2 | GO:0031005 | filamin binding(GO:0031005) |
| 3.5 | 10.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 3.5 | 10.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 3.5 | 24.7 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 3.5 | 6.9 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
| 3.5 | 10.4 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 3.4 | 17.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 3.4 | 126.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 3.4 | 13.6 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 3.4 | 10.1 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 3.4 | 20.2 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 3.4 | 16.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 3.4 | 63.9 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 3.3 | 16.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 3.3 | 10.0 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 3.3 | 3.3 | GO:0010181 | FMN binding(GO:0010181) |
| 3.3 | 26.5 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 3.3 | 3.3 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 3.3 | 23.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 3.3 | 22.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 3.3 | 22.8 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 3.2 | 16.2 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 3.2 | 32.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 3.2 | 9.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 3.2 | 12.7 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 3.2 | 25.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 3.2 | 82.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 3.2 | 114.1 | GO:0030552 | cAMP binding(GO:0030552) |
| 3.2 | 12.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 3.2 | 343.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 3.1 | 43.9 | GO:0033691 | sialic acid binding(GO:0033691) |
| 3.1 | 12.3 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 3.1 | 24.6 | GO:0034711 | inhibin binding(GO:0034711) |
| 3.1 | 36.8 | GO:0043121 | neurotrophin binding(GO:0043121) |
| 3.1 | 42.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 3.1 | 15.3 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 3.0 | 42.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 3.0 | 30.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 3.0 | 27.4 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 3.0 | 9.1 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 3.0 | 3.0 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 3.0 | 12.1 | GO:0038132 | neuregulin binding(GO:0038132) |
| 3.0 | 18.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 3.0 | 38.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 3.0 | 3.0 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
| 2.9 | 8.8 | GO:0016992 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 2.9 | 2.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 2.9 | 31.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 2.9 | 17.3 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 2.9 | 11.5 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 2.9 | 20.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 2.8 | 11.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 2.8 | 19.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 2.8 | 14.1 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 2.8 | 8.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 2.8 | 28.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 2.8 | 8.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 2.8 | 5.6 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 2.8 | 16.8 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 2.8 | 5.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 2.8 | 19.5 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 2.8 | 49.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 2.8 | 41.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 2.8 | 8.3 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 2.8 | 19.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 2.7 | 11.0 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 2.7 | 24.6 | GO:0043426 | MRF binding(GO:0043426) |
| 2.7 | 8.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 2.7 | 10.8 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
| 2.6 | 23.7 | GO:0003910 | DNA ligase (ATP) activity(GO:0003910) |
| 2.6 | 7.9 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 2.6 | 5.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 2.6 | 57.6 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
| 2.6 | 7.8 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
| 2.6 | 25.9 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 2.6 | 41.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 2.5 | 7.6 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 2.5 | 10.1 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 2.5 | 5.0 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 2.5 | 15.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 2.5 | 7.5 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 2.5 | 14.9 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 2.5 | 9.9 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 2.5 | 14.9 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 2.5 | 14.8 | GO:0005499 | vitamin D binding(GO:0005499) |
| 2.5 | 27.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 2.5 | 9.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 2.4 | 34.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 2.4 | 2.4 | GO:0001846 | opsonin binding(GO:0001846) |
| 2.4 | 38.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 2.4 | 19.4 | GO:0016595 | glutamate binding(GO:0016595) |
| 2.4 | 7.3 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 2.4 | 7.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 2.4 | 7.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 2.4 | 30.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 2.4 | 9.5 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 2.3 | 32.9 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 2.3 | 7.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 2.3 | 23.0 | GO:0031433 | telethonin binding(GO:0031433) |
| 2.3 | 13.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 2.3 | 11.5 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 2.3 | 6.9 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 2.3 | 6.9 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 2.3 | 29.6 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 2.3 | 11.4 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 2.3 | 6.8 | GO:0035473 | lipase binding(GO:0035473) |
| 2.3 | 4.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 2.2 | 20.1 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
| 2.2 | 8.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 2.2 | 28.8 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 2.2 | 26.5 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 2.2 | 8.8 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 2.2 | 41.6 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 2.2 | 12.9 | GO:0008948 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
| 2.2 | 4.3 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
| 2.1 | 6.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 2.1 | 4.2 | GO:0009374 | biotin binding(GO:0009374) |
| 2.1 | 37.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 2.1 | 27.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 2.1 | 6.2 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 2.1 | 14.4 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 2.1 | 8.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 2.1 | 6.2 | GO:0032093 | SAM domain binding(GO:0032093) |
| 2.0 | 10.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 2.0 | 8.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 2.0 | 38.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 2.0 | 4.0 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 2.0 | 14.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 2.0 | 20.0 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 2.0 | 6.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 2.0 | 19.9 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 2.0 | 23.9 | GO:0031014 | troponin T binding(GO:0031014) |
| 2.0 | 9.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 2.0 | 5.9 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 2.0 | 9.8 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 2.0 | 97.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 1.9 | 5.8 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 1.9 | 21.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 1.9 | 48.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 1.9 | 5.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 1.9 | 19.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 1.9 | 11.6 | GO:0003796 | lysozyme activity(GO:0003796) |
| 1.9 | 9.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 1.9 | 11.4 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 1.9 | 7.6 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
| 1.9 | 5.7 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
| 1.9 | 49.2 | GO:0042166 | acetylcholine binding(GO:0042166) |
| 1.9 | 35.9 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 1.9 | 7.5 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 1.9 | 7.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 1.9 | 5.6 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 1.9 | 7.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 1.9 | 5.6 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 1.9 | 5.6 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 1.8 | 9.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 1.8 | 5.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 1.8 | 5.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 1.8 | 14.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 1.8 | 10.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.8 | 5.4 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 1.8 | 5.4 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 1.8 | 3.6 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 1.8 | 10.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.8 | 28.2 | GO:0017022 | myosin binding(GO:0017022) |
| 1.8 | 12.3 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 1.8 | 7.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 1.8 | 10.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 1.7 | 10.5 | GO:0005497 | androgen binding(GO:0005497) |
| 1.7 | 20.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 1.7 | 22.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 1.7 | 5.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 1.7 | 5.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 1.7 | 25.4 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 1.7 | 35.5 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 1.7 | 46.7 | GO:0070840 | dynein complex binding(GO:0070840) |
| 1.7 | 13.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 1.7 | 13.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 1.7 | 5.0 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 1.6 | 9.9 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 1.6 | 11.5 | GO:0008142 | oxysterol binding(GO:0008142) |
| 1.6 | 4.9 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.6 | 8.2 | GO:0002046 | opsin binding(GO:0002046) |
| 1.6 | 26.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 1.6 | 39.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 1.6 | 4.9 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 1.6 | 22.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 1.6 | 6.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 1.6 | 20.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 1.6 | 1.6 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 1.6 | 4.7 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 1.6 | 41.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 1.6 | 14.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 1.6 | 25.0 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 1.6 | 15.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 1.5 | 6.2 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 1.5 | 4.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 1.5 | 4.6 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) apolipoprotein A-I receptor binding(GO:0034191) |
| 1.5 | 41.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 1.5 | 12.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 1.5 | 6.1 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 1.5 | 6.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 1.5 | 12.1 | GO:0004875 | complement receptor activity(GO:0004875) |
| 1.5 | 6.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
| 1.5 | 14.9 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 1.5 | 5.9 | GO:0071253 | connexin binding(GO:0071253) |
| 1.5 | 25.3 | GO:0038191 | neuropilin binding(GO:0038191) |
| 1.5 | 5.9 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 1.5 | 3.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 1.5 | 5.9 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 1.5 | 17.7 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 1.5 | 19.1 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 1.5 | 406.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 1.5 | 7.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 1.5 | 5.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.5 | 5.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 1.4 | 44.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 1.4 | 37.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 1.4 | 4.3 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 1.4 | 14.3 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 1.4 | 7.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 1.4 | 12.8 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 1.4 | 9.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 1.4 | 12.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 1.4 | 43.6 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 1.4 | 4.2 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
| 1.4 | 2.8 | GO:0016594 | glycine binding(GO:0016594) |
| 1.4 | 128.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 1.4 | 2.8 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 1.4 | 15.2 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 1.4 | 5.5 | GO:0089720 | caspase binding(GO:0089720) |
| 1.4 | 9.6 | GO:0015643 | toxic substance binding(GO:0015643) |
| 1.4 | 4.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 1.3 | 10.8 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 1.3 | 63.3 | GO:0008009 | chemokine activity(GO:0008009) |
| 1.3 | 4.0 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.3 | 4.0 | GO:0001007 | transcription factor activity, core RNA polymerase III binding(GO:0000995) transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 1.3 | 2.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 1.3 | 8.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 1.3 | 13.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 1.3 | 2.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.3 | 13.0 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 1.3 | 6.5 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 1.3 | 11.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 1.3 | 5.2 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 1.3 | 37.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 1.3 | 27.0 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 1.3 | 7.7 | GO:0030275 | LRR domain binding(GO:0030275) |
| 1.3 | 3.8 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 1.3 | 12.7 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
| 1.3 | 17.8 | GO:0015250 | water channel activity(GO:0015250) |
| 1.3 | 3.8 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 1.3 | 5.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 1.3 | 58.1 | GO:0005254 | chloride channel activity(GO:0005254) |
| 1.3 | 6.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 1.3 | 5.0 | GO:0004803 | transposase activity(GO:0004803) |
| 1.3 | 1.3 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 1.3 | 3.8 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
| 1.2 | 123.6 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 1.2 | 58.5 | GO:0030507 | spectrin binding(GO:0030507) |
| 1.2 | 17.3 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
| 1.2 | 7.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.2 | 24.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 1.2 | 41.5 | GO:0042805 | actinin binding(GO:0042805) |
| 1.2 | 59.7 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 1.2 | 26.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 1.2 | 3.6 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 1.2 | 3.6 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 1.2 | 3.5 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 1.2 | 23.3 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 1.2 | 18.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 1.2 | 5.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 1.2 | 9.3 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 1.2 | 6.9 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 1.1 | 9.1 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
| 1.1 | 3.4 | GO:0015116 | sulfate transmembrane transporter activity(GO:0015116) |
| 1.1 | 6.7 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
| 1.1 | 7.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 1.1 | 24.2 | GO:0030506 | ankyrin binding(GO:0030506) |
| 1.1 | 4.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 1.1 | 3.3 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
| 1.1 | 5.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 1.1 | 8.7 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 1.1 | 9.7 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 1.1 | 5.4 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 1.1 | 4.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 1.1 | 17.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 1.1 | 1.1 | GO:0005267 | potassium channel activity(GO:0005267) |
| 1.1 | 2.1 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 1.1 | 10.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 1.0 | 7.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 1.0 | 9.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 1.0 | 17.8 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 1.0 | 6.3 | GO:0003680 | AT DNA binding(GO:0003680) |
| 1.0 | 15.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 1.0 | 5.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 1.0 | 6.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 1.0 | 3.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 1.0 | 12.3 | GO:0019864 | IgG binding(GO:0019864) |
| 1.0 | 65.1 | GO:0019905 | syntaxin binding(GO:0019905) |
| 1.0 | 3.0 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
| 1.0 | 83.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 1.0 | 6.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 1.0 | 3.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 1.0 | 10.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 1.0 | 80.5 | GO:0005179 | hormone activity(GO:0005179) |
| 1.0 | 8.8 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
| 1.0 | 2.9 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 1.0 | 9.7 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 1.0 | 4.8 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 1.0 | 5.8 | GO:0046790 | virion binding(GO:0046790) |
| 1.0 | 8.7 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 1.0 | 23.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 1.0 | 2.9 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.9 | 2.8 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
| 0.9 | 4.7 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
| 0.9 | 2.8 | GO:0004769 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
| 0.9 | 5.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.9 | 3.7 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.9 | 6.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 0.9 | 0.9 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.9 | 2.7 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.9 | 43.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.9 | 4.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
| 0.9 | 4.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.9 | 2.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.9 | 13.3 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.9 | 13.2 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 0.9 | 3.5 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.9 | 7.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.9 | 24.3 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.9 | 3.5 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.9 | 3.5 | GO:0035939 | microsatellite binding(GO:0035939) |
| 0.9 | 2.6 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.9 | 6.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.9 | 0.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.9 | 12.0 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.9 | 1.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.8 | 5.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.8 | 2.5 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.8 | 19.1 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
| 0.8 | 3.3 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.8 | 14.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.8 | 7.3 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.8 | 25.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.8 | 4.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.8 | 2.4 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.8 | 0.8 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
| 0.8 | 8.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.8 | 18.3 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.8 | 2.3 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.8 | 2.3 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
| 0.8 | 4.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.8 | 8.4 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.7 | 6.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.7 | 2.2 | GO:0008430 | selenium binding(GO:0008430) |
| 0.7 | 9.6 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) TFIIB-class transcription factor binding(GO:0001093) |
| 0.7 | 8.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.7 | 9.5 | GO:0036122 | BMP binding(GO:0036122) |
| 0.7 | 2.2 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.7 | 16.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.7 | 15.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.7 | 9.3 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.7 | 5.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.7 | 13.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.7 | 10.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.7 | 12.7 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.7 | 4.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.7 | 0.7 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.7 | 4.2 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.7 | 18.0 | GO:0022834 | ligand-gated ion channel activity(GO:0015276) ligand-gated channel activity(GO:0022834) |
| 0.7 | 10.4 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.7 | 2.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 0.7 | 1.3 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.7 | 15.2 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
| 0.7 | 6.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.7 | 8.6 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.7 | 2.0 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.7 | 3.3 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.6 | 12.2 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.6 | 14.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.6 | 5.1 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.6 | 12.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.6 | 2.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.6 | 3.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.6 | 3.1 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.6 | 8.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.6 | 1.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.6 | 9.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.6 | 6.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.6 | 6.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.6 | 1.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.6 | 18.6 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.6 | 6.6 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
| 0.6 | 8.9 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.6 | 4.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.6 | 164.6 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.6 | 3.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.6 | 15.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
| 0.6 | 8.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.6 | 6.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.6 | 21.5 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.6 | 8.7 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.6 | 2.8 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.6 | 1.7 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.5 | 3.8 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.5 | 19.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.5 | 4.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.5 | 3.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.5 | 2.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.5 | 2.1 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 0.5 | 1.6 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.5 | 2.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.5 | 3.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.5 | 6.6 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.5 | 1.5 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.5 | 12.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.5 | 17.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.5 | 5.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.5 | 14.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
| 0.5 | 0.5 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.5 | 3.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.5 | 1.9 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.5 | 1.4 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.5 | 8.1 | GO:0051184 | cofactor transporter activity(GO:0051184) |
| 0.5 | 0.9 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
| 0.5 | 43.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.5 | 10.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.5 | 7.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.5 | 2.3 | GO:0070404 | NADH binding(GO:0070404) |
| 0.5 | 1.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.5 | 12.8 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.5 | 7.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.5 | 1.8 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.4 | 6.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
| 0.4 | 1.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.4 | 1.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.4 | 1.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
| 0.4 | 0.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.4 | 6.6 | GO:0008143 | poly(A) binding(GO:0008143) |
| 0.4 | 7.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.4 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.4 | 2.2 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.4 | 2.9 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
| 0.4 | 2.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.4 | 2.5 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.4 | 1.2 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.4 | 1.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.4 | 2.0 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.4 | 83.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.4 | 6.3 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.4 | 1.6 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.4 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.4 | 10.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.4 | 1.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.4 | 7.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.4 | 0.8 | GO:0004630 | phospholipase D activity(GO:0004630) |
| 0.4 | 4.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.4 | 0.8 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.4 | 1.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
| 0.4 | 12.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.4 | 0.7 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.4 | 1.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.4 | 1.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.4 | 13.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.4 | 1.8 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
| 0.4 | 10.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.4 | 3.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.3 | 1.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.3 | 3.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.3 | 1.7 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.3 | 7.8 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.3 | 7.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.3 | 23.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.3 | 1.0 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.3 | 4.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.3 | 6.5 | GO:0043621 | protein self-association(GO:0043621) |
| 0.3 | 45.7 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.3 | 5.4 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.3 | 2.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.3 | 1.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 2.2 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.3 | 14.5 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.3 | 0.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 1.1 | GO:0005310 | dicarboxylic acid transmembrane transporter activity(GO:0005310) |
| 0.3 | 3.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.3 | 284.8 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.3 | 2.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.3 | 1.1 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.3 | 2.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.3 | 1.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.3 | 2.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.3 | 0.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.3 | 2.3 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.3 | 7.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.3 | 0.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 29.0 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.2 | 0.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.2 | 1.7 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.2 | 0.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.2 | 8.6 | GO:0002039 | p53 binding(GO:0002039) |
| 0.2 | 3.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.2 | 1.9 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.2 | 1.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 1.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.2 | 0.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.2 | 1.1 | GO:0052655 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 0.9 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.2 | 0.7 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 0.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 0.2 | 1.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 1.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.2 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 0.8 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
| 0.2 | 2.0 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.2 | 1.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.1 | 0.4 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.1 | 1.8 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.1 | 2.1 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 8.1 | GO:0020037 | heme binding(GO:0020037) |
| 0.1 | 0.5 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.1 | 0.5 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.1 | 6.8 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.1 | 0.9 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.1 | 1.0 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 0.4 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
| 0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.1 | 1.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 50.0 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.1 | 0.6 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.1 | 0.4 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.1 | 12.0 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
| 0.1 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.1 | 0.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 1.4 | GO:0017171 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
| 0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 0.7 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.0 | 0.2 | GO:0039552 | RIG-I binding(GO:0039552) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.6 | 116.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
| 3.6 | 7.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 3.5 | 253.8 | PID RHOA PATHWAY | RhoA signaling pathway |
| 3.3 | 101.0 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 3.0 | 51.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 2.4 | 2.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 2.4 | 12.0 | PID EPO PATHWAY | EPO signaling pathway |
| 2.3 | 25.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
| 2.2 | 15.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 2.2 | 19.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 2.2 | 17.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 2.2 | 8.7 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 2.1 | 39.4 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 2.0 | 31.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 2.0 | 58.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 1.9 | 15.0 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 1.8 | 15.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 1.8 | 253.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 1.7 | 34.1 | PID BCR 5PATHWAY | BCR signaling pathway |
| 1.6 | 4.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 1.6 | 76.8 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 1.6 | 86.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 1.6 | 1.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.5 | 26.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 1.5 | 30.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 1.5 | 28.6 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 1.5 | 31.2 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 1.5 | 22.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 1.4 | 11.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 1.4 | 17.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 1.3 | 38.9 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 1.3 | 11.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 1.3 | 55.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 1.2 | 31.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 1.1 | 39.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 1.0 | 96.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 1.0 | 57.0 | PID ARF6 PATHWAY | Arf6 signaling events |
| 1.0 | 38.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 1.0 | 2.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.9 | 8.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.9 | 14.6 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.9 | 24.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.9 | 6.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.9 | 13.1 | PID SHP2 PATHWAY | SHP2 signaling |
| 0.9 | 26.1 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.8 | 42.4 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.8 | 213.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.8 | 1.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.7 | 22.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.7 | 27.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.7 | 35.2 | PID FGF PATHWAY | FGF signaling pathway |
| 0.7 | 37.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.7 | 35.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.7 | 117.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.7 | 25.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.7 | 28.7 | PID ATM PATHWAY | ATM pathway |
| 0.7 | 4.8 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.7 | 12.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.6 | 3.2 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.6 | 24.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.6 | 17.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.6 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.6 | 46.4 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.6 | 13.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.6 | 12.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.6 | 9.9 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.6 | 5.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.6 | 11.6 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.6 | 8.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.6 | 2.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 0.5 | 6.9 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.5 | 19.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.5 | 2.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.5 | 173.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.5 | 7.7 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.4 | 12.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.4 | 1.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 18.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.4 | 2.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 5.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.4 | 21.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.3 | 5.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.3 | 1.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.3 | 2.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.3 | 53.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.3 | 3.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 4.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.3 | 2.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 3.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.2 | 1.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.2 | 2.3 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.2 | 6.0 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.2 | 1.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.2 | 3.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.2 | 13.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.2 | 10.0 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 1.6 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 1.3 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 0.4 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.1 | 2.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 4.8 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 0.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.1 | 0.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.4 | 92.6 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 4.7 | 259.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 4.6 | 69.7 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 4.5 | 169.7 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 4.4 | 80.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 4.4 | 8.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 3.9 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 3.9 | 47.0 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 3.9 | 81.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 3.5 | 10.6 | REACTOME TRANSCRIPTION | Genes involved in Transcription |
| 3.5 | 34.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 3.4 | 48.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 3.4 | 30.4 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 3.4 | 60.4 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 3.3 | 32.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 3.3 | 9.8 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
| 3.1 | 73.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 3.0 | 36.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 2.9 | 2.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 2.8 | 42.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 2.8 | 59.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 2.8 | 55.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 2.7 | 41.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 2.6 | 2.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
| 2.5 | 54.2 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
| 2.4 | 81.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 2.2 | 26.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 2.2 | 26.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 2.1 | 66.1 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 2.1 | 25.5 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 2.1 | 39.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 2.1 | 14.6 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 2.0 | 52.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 2.0 | 33.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 1.9 | 35.1 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 1.9 | 40.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.9 | 37.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 1.9 | 18.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 1.9 | 39.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 1.8 | 53.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 1.8 | 7.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 1.8 | 96.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 1.8 | 65.6 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 1.7 | 52.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 1.7 | 17.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 1.7 | 30.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 1.7 | 18.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 1.7 | 20.3 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 1.7 | 42.2 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 1.7 | 13.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 1.6 | 29.6 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
| 1.5 | 69.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 1.4 | 7.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 1.4 | 19.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 1.4 | 31.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 1.4 | 9.6 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 1.4 | 27.2 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 1.4 | 35.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 1.3 | 2.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
| 1.3 | 8.0 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 1.3 | 31.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 1.3 | 34.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 1.3 | 109.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 1.3 | 25.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 1.3 | 22.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 1.3 | 45.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 1.3 | 12.5 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 1.2 | 35.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 1.2 | 1.2 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
| 1.2 | 23.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 1.2 | 14.5 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 1.2 | 7.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 1.2 | 45.3 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 1.2 | 18.9 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 1.2 | 39.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 1.2 | 32.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 1.2 | 49.6 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 1.2 | 18.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 1.1 | 57.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 1.1 | 11.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 1.1 | 26.2 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 1.1 | 24.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 1.1 | 17.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 1.1 | 46.1 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 1.1 | 20.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 1.0 | 20.7 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 1.0 | 3.9 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 1.0 | 53.7 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 1.0 | 5.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.9 | 24.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.9 | 30.1 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.9 | 17.7 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.9 | 37.2 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.9 | 91.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.9 | 38.9 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.9 | 1.8 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.9 | 5.3 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
| 0.9 | 15.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.8 | 164.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.8 | 5.0 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.8 | 39.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.8 | 14.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.8 | 36.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.8 | 9.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.8 | 8.0 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.8 | 3.1 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.7 | 13.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.7 | 33.6 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
| 0.7 | 12.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.7 | 15.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.7 | 9.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.6 | 20.1 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.6 | 161.1 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.6 | 1.8 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.6 | 1.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.6 | 12.1 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.5 | 9.3 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.5 | 8.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.5 | 5.4 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
| 0.5 | 6.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.5 | 3.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.5 | 36.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.5 | 11.8 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.5 | 14.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
| 0.5 | 13.4 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.5 | 13.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.5 | 0.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.5 | 9.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.5 | 17.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
| 0.4 | 6.2 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.4 | 3.3 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.4 | 4.9 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.4 | 4.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.4 | 5.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.4 | 3.6 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.4 | 2.5 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.3 | 8.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.3 | 4.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.3 | 3.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 3.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.3 | 1.8 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.3 | 3.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 5.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.2 | 3.3 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.2 | 5.8 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.2 | 4.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.2 | 25.4 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.2 | 3.1 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.2 | 3.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.2 | 16.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.2 | 26.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.4 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
| 0.1 | 1.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.1 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 4.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.1 | 0.4 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 7.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 2.5 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
| 0.1 | 1.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 4.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 0.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.1 | 1.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.1 | 0.4 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
| 0.0 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.0 | 0.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.0 | 0.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 2.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.0 | 1.3 | REACTOME PHOSPHOLIPASE C MEDIATED CASCADE | Genes involved in Phospholipase C-mediated cascade |
| 0.0 | 0.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.0 | 0.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |